The parallel import is a type of circulation of goods between the countries of the European Economic Area which consists in purchasing the medicinal products in the potentially cheapest market, repacking them into new packages and providing them with the translated leaflets. Then the medicines are distributed to the pharmaceutical warehouses, hospitals and pharmacies at prices lower than the local prices.
All stages of the process of parallel import: purchase, delivery, repacking, serialization and distribution of medicinal products are supervised by competent bodies: the Chief Pharmaceutical Inspector, Minister of Health, and the President of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products.
The medicinal product from the parallel import contains the same active substance, same strength and method of administration as the medicinal product with the Marketing Authorisation in the country origin (purchase) and in the destination country (e.g. in Poland). It should be not confused with its equivalents (the generic drugs).
Do you want to know more details about our offer? Get started today! Call us or write to us and we will select the best solution for you.